Lataa...
Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity
The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia. We reported comparative in vitro studies of combination effects of different cephalosporins (i.e., cefazolin...
Tallennettuna:
| Julkaisussa: | Front Microbiol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5435797/ https://ncbi.nlm.nih.gov/pubmed/28572795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2017.00884 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|